Carrie L. Blout, MS, CGC
Carrie Blout, MS, CGC, is Adjunct Assistant Professor in the MS Genetic Counseling program at MGH Institute of Health Professions. She is a Senior Genetic Counselor and Project Manager at Brigham and Women’s Hospital (BWH) and is the Director of Research Development for the Genomes2People translational research group.
Carrie plays an active role in project management and/or advising for several research projects at BWH including: the MedSeq Project, a randomized control trial exploring the medical, behavioral and economic outcomes of whole genome sequencing, the MilSeq Project, a study of genomic sequencing in the US Air Force, the Partners HealthCare Biobank and the NIH eMERGE consortium aimed at returning unanticipated actionable genetic findings to Biobank participants, and the Precision Medicine and Treatment (PreEMT) study, aimed at developing an economic model for newborn genomic sequencing. In her current role, she also helps to foster new collaborations and draft new grant proposals.
Previously, Carrie worked at Johns Hopkins coordinating clinical drug trials, enrolling individuals with Down syndrome and Achondroplasia, and providing genetic counseling to patients in the Cleft Clinic. She has also worked at Nationwide Children’s Hospital as a general/pediatric genetic counselor and at the University of Maryland Medical Center & Maryland Department of Health and Mental Hygiene in newborn screening.
Ms. Blout volunteers for the National Society of Genetic Counselors: she currently serves on the annual conference Program Committee, and in the past, she has served on the NSGC Board of Directors, chaired the Public Policy Committee, the Webinar Subcommittee, and the Pediatric & General Genetics Special Interest Group. Carrie received her MS in Genetic Counseling from the University of Pittsburgh School of Public Health in 2006.
Carrie’s research interests include exploring the medical, behavioral, and economic impact of genomic sequencing in both healthy populations and populations with suspected genetic disease. She is also committed to studying the return of unanticipated genetic results. Carrie is also interested in exploring how fears of insurance discrimination influence patient decision making regarding whether or not to pursue genetic testing.
BS, Biology, Dickinson College, Carlisle, PA
MS, Genetic Counseling, University of Pittsburgh School of Public Health, Pittsburgh, PA
Christensen KD, Vassy JL, Phillips KA, Blout CL, Azzariti DR, Lu CY, Robinson JO, Lee K, Douglas MP, Yeh JM, Machini K, Stout NK, Rehm HL, McGuire AL, Green RC, Dukhovny D. (2018) Short-term costs of integrating whole-genome sequencing into primary care and cardiology settings: a pilot randomized trial. Genet Med. EPub ahead of print.
Amendola LM, Robinson JO, Hart R, Biswas S, Lee K, Bernhardt BA, East K, Gilmore MJ, Kauffman TL, Lewis KL, Roche M, Scollon S, Wynn J, Blout C. Why Patients Decline Genomic Sequencing Studies: Experiences from the CSER Consortium (2018) J Genet Couns. EPub ahead of print.
Vassy JL, Christensen KD, Schonman EF, Blout CL, Robinson JO, Krier JB, Diamond PM, Lebo M, Machini K, Azzariti DR, Dukhovny D, Bates DW, MacRae CA, Murray MF, McGuire AL, Green RC, for the MedSeq Project. (2017) The Impact of Whole Genome Sequencing on Primary Care and Outcomes of Healthy Adult Patients: A Pilot Randomized Trial. Annals Intern Med. EPub ahead of print.
Bergner A, Bollinger J, Raraigh K, Tichnell C, Murray B, Blout C, Telegrafi A, James C. (2014) Informed consent for exome sequencing research in families with genetic disease: The emerging issue of incidental findings. (2014) American Journal of Medical Genetics. 164(11):2745-52.
Blout, C. Walsh Vockley, A Gaviglio, M. Fox, L Williamson Dean, The Newborn screening task for on behalf of the NSGC Public Policy Committee. (2013) Newborn Screening: Education Consent, and the Residual Blood Spot. The Position of the National Society of Genetic Counselors. (2013) C. The Journal of Genetic Counseling. 23(1):16-19.